Sg3 Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Put Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $748,260 - $1.31 Million	-9,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $5.34 Million - $6.93 Million	-48,500 Reduced 84.35%	9,000 $1.07 Million
Q4 2021 Feb 15, 2022	BUY	$99.73 - $148.48 $747,975 - $1.11 Million	7,500 Added 15.0%	57,500 $7.92 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $2.14 Million - $3.06 Million	-33,400 Reduced 40.05%	50,000 $3.42 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $2.17 Million - $3.28 Million	33,400 Added 66.8%	83,400 $7.15 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $2.95 Million - $3.9 Million	50,000 New	50,000 $3.25 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.32B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.